Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM - Jan 7, 2016

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jbuffett62

Rank: Treasurer [?]

Points: 480 [?]

Votes: 13 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - Jan 7, 2016 - Details

in response to

Re: AGM - Jan 7, 2016 - Details

BearDownAZ

posted on Jan 08, 2016 01:46PM

I realize both companies were always potentially on the selling block but does it strike you as though the sale of RVX has been somewhat ramped up(or both?)?

Thanks

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply